Beauty Health Shares Scheduled to Reverse Split on Wednesday, October 14th (NASDAQ:SKIN)

The Beauty Health Company (NASDAQ:SKIN)’s stock is scheduled to reverse split on the morning of Wednesday, October 14th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, October 13th.

Beauty Health Stock Down 3.3%

NASDAQ:SKIN opened at $0.55 on Friday. The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76. The firm has a market cap of $71.58 million, a P/E ratio of -2.50 and a beta of 1.05. Beauty Health has a fifty-two week low of $0.50 and a fifty-two week high of $1.74. The firm has a 50-day simple moving average of $0.66 and a two-hundred day simple moving average of $0.74.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, August 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.02). Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The business had revenue of $72.11 million during the quarter, compared to analysts’ expectations of $74.45 million. Analysts predict that Beauty Health will post -0.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on SKIN. Weiss Ratings cut Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 23rd. TD Cowen decreased their target price on Beauty Health from $1.00 to $0.90 and set a “hold” rating for the company in a research report on Wednesday, August 12th. Finally, Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $1.38.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Bank of America Corp DE boosted its position in Beauty Health by 19.2% in the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after purchasing an additional 17,088 shares during the last quarter. Diversified Trust Co bought a new position in shares of Beauty Health in the 1st quarter worth approximately $25,000. Renaissance Technologies LLC lifted its stake in shares of Beauty Health by 29.6% in the 1st quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock worth $253,000 after purchasing an additional 64,900 shares during the period. Finally, Capricorn Fund Managers Ltd purchased a new position in shares of Beauty Health in the first quarter worth approximately $17,270,000. Institutional investors own 93.26% of the company’s stock.

About Beauty Health

BeautyHealth is a global health and beauty company focused on creating technology-enabled products and experiences for skin health. Its primary brand is Hydrafacial, which offers non-invasive skin treatments that combine cleansing, exfoliation, extraction and hydration with professional-grade devices, serums and treatment boosters.

The company also provides products and systems designed for complementary aesthetic and wellness applications, including Syndeo, a connected Hydrafacial delivery system; Keravive, a scalp-health treatment; and SkinStylus, a microneedling platform.